Jay Bradner's Leadership and Research Vision at Novartis

In this case study, Jay Bradner, President of Novartis Institutes for BioMedical Research, discusses his transition from academia to industry, his leadership style, and his commitment to innovative drug discovery. He emphasizes the importance of open-source science and collaboration in accelerating research to deliver definitive treatments for patients with serious illnesses. Discover how his experiences as a physician-scientist shape his vision for the future of biomedical research.